Active substance
Cyclopentolate
- SFDA 12
- US FDA 13
- Health Canada 3
- US price lines 6
- NHS prices 4
- WHO EML 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MINIMS CYCLOPENTOLATE HCL 0.5% | 0.5 % | Eye drops, solution · Ophthalmic use | 20 Single Dose Container | SAR 60.05 | NCE · Prescription | CHAUVIN BAUSCH & LOMB | Valid |
| MINIMS CYCLOPENTOLATE HCL 1% | 1 % | Eye drops, solution · Ophthalmic use | 20 Single Dose Container | SAR 60.10 | Generic · Prescription | CHAUVIN BAUSCH & LOMB | Valid |
| PENTOLATE 1% EYE DROPS | 1 % | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 9.00 | Generic · Prescription | Amman Pharmaceutical Industries (API) | Valid |
| SECLODYN 1% EYE DROPS | 1 % | Eye drops, solution · Ophthalmic use | 20 Single Dose Container | SAR 49.00 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| COLIRCUSI-CICLOPLEGIC 1% | 1 % | Eye drops, solution · Ocular use | 1 Dropper Container | SAR 5.55 | Generic · Prescription | ALCON CUSI | Withdrawn by MAH · Not Marketed |
| CYCLATE 0.5% EYE DROPS | 0.5 % | Eye drops, solution · Ocular use | 1 Dropper Container | SAR 11.05 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| CYCLATE 1% EYE DROPS | 1 % | Eye drops, solution · Ocular use | 1 Dropper Container | SAR 13.10 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| CYCLATE 2% EYE DROPS | 2 % | Eye drops, solution · Ocular use | 1 Dropper Container | SAR 20.00 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| CYCLOGYL EYE DROPS 1% | 1 % | Eye drops, solution · Ophthalmic use | 1 Dropper Container | SAR 15.35 | Generic · Prescription | ALCON LABORATORIES | Withdrawn by MAH · Not Marketed |
| CYCLOGYL EYE DROPS 2% | 2 % | Eye drops, solution · Ocular use | 1 Dropper Container | SAR 26.20 | Generic · Prescription | ALCON LABORATORIES | Withdrawn by MAH · Not Marketed |
| CYCLOPENTOLATE 0.5%THILO EYE DROPS | 0.5 % | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 9.30 | Generic · Prescription | DR. THILO LABORATORIES | Withdrawn by MAH · Not Marketed |
| CYCLOPENTOLATE 1% THILO EYE DROPS | 1 % | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 10.80 | Generic · Prescription | DR. THILO LABORATORIES | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
NON-INFECTIOUS UVEITIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CYCLOGYL | 2% | solution/drops · ophthalmic | ALCON LABS INC | Prescription | 31 Jul 1974 |
| CYCLOGYL | 0.5% | solution/drops · ophthalmic | ALCON LABS INC | Prescription | 31 Jul 1974 |
| CYCLOGYL | 1% | solution/drops · ophthalmic | ALCON LABS INC | Prescription | 31 Jul 1974 |
| PENTOLAIR | 1% | solution/drops · ophthalmic | BAUSCH AND LOMB INC | Prescription | 29 Apr 1994 |
| AKPENTOLATE | 1% | solution/drops · ophthalmic | RISING | Prescription | 13 Jan 1997 |
| AKPENTOLATE | 2% | solution/drops · ophthalmic | RISING | Prescription | 13 Jan 1997 |
| CYCLOPENTOLATE HYDROCHLORIDE | 1% | solution/drops · ophthalmic | SOLA BARNES HIND | Discontinued | 22 Nov 1974 |
| AK-PENTOLATE | 1% | solution/drops · ophthalmic | EPIC PHARMA LLC | Discontinued | 10 Apr 1979 |
| CYCLOPENTOLATE HYDROCHLORIDE | 1% | solution/drops · ophthalmic | ALCON PHARMS LTD | Discontinued | 24 Jan 1991 |
| CYCLOPENTOLATE HYDROCHLORIDE | 0.5% | solution/drops · ophthalmic | SCIEGEN PHARMS | Discontinued | 9 Dec 2015 |
| CYCLOPENTOLATE HYDROCHLORIDE | 1% | solution/drops · ophthalmic | SOLA BARNES HIND | Discontinued | |
| PENTOLAIR | 1% | solution/drops · ophthalmic | PHARMAFAIR | Discontinued | |
| PENTOLAIR | 0.5% | solution/drops · ophthalmic | PHARMAFAIR | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CYCLOGYL | 00252506 | 1 % / W/V | DROPS · OPHTHALMIC | ALCON CANADA INC |
| MINIMS CYCLOPENTOLATE HYDROCHLORIDE | 02148382 | 1 % / W/V | SOLUTION · OPHTHALMIC | BAUSCH & LOMB INC |
| ODAN-CYCLOPENTOLATE | 00626627 | 1 % | SOLUTION · OPHTHALMIC | ODAN LABORATORIESLTD |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CYCLOGYL 0.5% EYE DROPS | $6.40467 | per ML | 23 Sep 2026 |
| US NADAC | CYCLOGYL 2% EYE DROPS | $22.096 | per ML | 23 Sep 2026 |
| US NADAC | CYCLOGYL 2% EYE DROPS | $14.6264 | per ML | 23 Sep 2026 |
| US NADAC | CYCLOPENTOLATE 1% EYE DROP | $0.86977 | per ML | 23 Sep 2026 |
| US NADAC | CYCLOPENTOLATE 1% EYE DROPS | $2.64533 | per ML | 23 Sep 2026 |
| US NADAC | CYCLOPENTOLATE 1% EYE DROPS | $0.86977 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Cyclopentolate 0.5% eye drops | £8.08 | 5 ml | 1 Oct 2026 |
| NHS Drug Tariff | Cyclopentolate 0.5% eye drops 0.5ml unit dose preservative free | £13.41 | 20 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Cyclopentolate 1% eye drops | £8.08 | 5 ml | 1 Oct 2026 |
| NHS Drug Tariff | Cyclopentolate 1% eye drops 0.5ml unit dose preservative free | £13.71 | 20 unit dose | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 14.1. Diagnostic agents > Ophthalmic medicines · core
Therapeutic equivalent to tropicamide for Cycloplegic drug - 21.5. Ophthalmological preparations > Mydriatics · core
Therapeutic equivalent to atropine for Anterior uveitis
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.